Market Overview:
The global peptides market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the peptides market can be attributed to the increasing prevalence of chronic diseases, such as diabetes, cancer, and osteoporosis. Additionally, the increasing demand for novel therapeutics is also contributing to the growth of this market. The insulin segment is expected to dominate the global peptides market during the forecast period owing to its high usage in the treatment of diabetes mellitus.
Product Definition:
A peptide is a molecule composed of two or more amino acids linked by peptide bonds. The sequence of amino acids in a peptide determines its three-dimensional structure and, consequently, its function. Peptides play important roles in many biological processes, including protein synthesis, cell signaling, and the immune response.
Insulin:
Insulin is a peptide hormone, which facilitates the entry of glucose into the blood cells. The body's inability to produce an appropriate amount of insulin leads to diabetes mellitus. This condition is also known as insulin deficiency or hypoglycemia. Insulin can be administered through various routes, including intravenous, subcutaneous and oral routes.
Teriparatide:
Teriparatide, also known as Januvia, is a patented drug by Merck KGaA. It is a type of peptide growth factor that increases the growth of insulin-producing cells in the pancreas. The drug was approved by the U.S Food and Drug Administration (FDA) for treatment of diabetes in November 2003 and received approval in Europe two years later.
Application Insights:
The infectious diseases segment dominated the global peptides market in terms of revenue share in 2017. The growing prevalence of infectious diseases, such as HIV, tuberculosis and influenza is anticipated to drive the demand for peptide-based drugs over the forecast period. Moreover, an increase in incidence of chronic respiratory disorders is expected to augment market growth during the forecast period. For instance, according to a study published by WHO in 2018 regarding asthma prevalence around 1 billion people across 85% of world population suffer from asthma.
The diabetes segment accounted for a significant share owing to increasing incidence rates and awareness about lifestyle modifications related to maintaining normal blood glucose levels among patients suffering from diabetes or at risk factors for developing diabetes (such as obesity). According to data published by International Diabetes Federation (IDF) regarding year-end 2015; 863 million people were living with diabetes worldwide while 742 million had been diagnosed and 250 million were undiagnosed till then.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in prevalence of chronic diseases, such as diabetes and cancer. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by companies and academic institutes for development of novel peptide therapeutics. Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising awareness about peptide-based pharmaceuticals among patients, physicians, and researchers. Moreover, growing penetration of Abbott’s Teriparatide below its cost price may encourage other players operating in this space also offer it at a lower price which will further boost revenue generation from this region.
Growth Factors:
- Increasing demand for peptides in the pharmaceutical and biotechnology industries for the development of novel drugs and therapies.
- Growing research on peptides for use in diagnostics and biomarkers.
- Rising demand from cosmetic manufacturers for peptide-based anti-aging products.
- increasing application of peptides in nutraceuticals and functional foods industry . 5 Increased investment by leading players to develop new technologies and expand their product portfolios
Scope Of The Report
Report Attributes
Report Details
Report Title
Peptides Market Research Report
By Type
Insulin, Teriparatide, Liraglutide, Leuprolide
By Application
Diabetes, Infectious Diseases, Cancer, Osteoporosis
By Companies
Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech, Samarth Life Sciences Pvt. Ltd., VHB Life Sciences Limited, Celon Laboratories Pvt. Ltd., United Biotech(P) Limited
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Peptides Market Report Segments:
The global Peptides market is segmented on the basis of:
Types
Insulin, Teriparatide, Liraglutide, Leuprolide
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes, Infectious Diseases, Cancer, Osteoporosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cipla Ltd.
- Emcure Pharmaceuticals Pvt. Ltd.
- Gland Pharma Limited
- Troikaa Pharmaceuticals Ltd.
- Biological E Limited
- Bharat Biotech
- Samarth Life Sciences Pvt. Ltd.
- VHB Life Sciences Limited
- Celon Laboratories Pvt. Ltd.
- United Biotech(P) Limited
Highlights of The Peptides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Insulin
- Teriparatide
- Liraglutide
- Leuprolide
- By Application:
- Diabetes
- Infectious Diseases
- Cancer
- Osteoporosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Peptides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Peptides are a type of protein. They are made up of smaller amino acids, and they can be folded into different shapes to create proteins.
Some of the key players operating in the peptides market are Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech, Samarth Life Sciences Pvt. Ltd., VHB Life Sciences Limited, Celon Laboratories Pvt. Ltd., United Biotech(P) Limited.
The peptides market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peptides Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Peptides Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Peptides Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Peptides Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Peptides Market Size & Forecast, 2018-2028
4.5.1 Peptides Market Size and Y-o-Y Growth
4.5.2 Peptides Market Absolute $ Opportunity
Chapter 5 Global Peptides Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Peptides Market Size Forecast by Type
5.2.1 Insulin
5.2.2 Teriparatide
5.2.3 Liraglutide
5.2.4 Leuprolide
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Peptides Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Peptides Market Size Forecast by Applications
6.2.1 Diabetes
6.2.2 Infectious Diseases
6.2.3 Cancer
6.2.4 Osteoporosis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Peptides Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Peptides Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Peptides Analysis and Forecast
9.1 Introduction
9.2 North America Peptides Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Peptides Market Size Forecast by Type
9.6.1 Insulin
9.6.2 Teriparatide
9.6.3 Liraglutide
9.6.4 Leuprolide
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Peptides Market Size Forecast by Applications
9.10.1 Diabetes
9.10.2 Infectious Diseases
9.10.3 Cancer
9.10.4 Osteoporosis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Peptides Analysis and Forecast
10.1 Introduction
10.2 Europe Peptides Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Peptides Market Size Forecast by Type
10.6.1 Insulin
10.6.2 Teriparatide
10.6.3 Liraglutide
10.6.4 Leuprolide
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Peptides Market Size Forecast by Applications
10.10.1 Diabetes
10.10.2 Infectious Diseases
10.10.3 Cancer
10.10.4 Osteoporosis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Peptides Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Peptides Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Peptides Market Size Forecast by Type
11.6.1 Insulin
11.6.2 Teriparatide
11.6.3 Liraglutide
11.6.4 Leuprolide
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Peptides Market Size Forecast by Applications
11.10.1 Diabetes
11.10.2 Infectious Diseases
11.10.3 Cancer
11.10.4 Osteoporosis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Peptides Analysis and Forecast
12.1 Introduction
12.2 Latin America Peptides Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Peptides Market Size Forecast by Type
12.6.1 Insulin
12.6.2 Teriparatide
12.6.3 Liraglutide
12.6.4 Leuprolide
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Peptides Market Size Forecast by Applications
12.10.1 Diabetes
12.10.2 Infectious Diseases
12.10.3 Cancer
12.10.4 Osteoporosis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Peptides Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Peptides Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Peptides Market Size Forecast by Type
13.6.1 Insulin
13.6.2 Teriparatide
13.6.3 Liraglutide
13.6.4 Leuprolide
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Peptides Market Size Forecast by Applications
13.10.1 Diabetes
13.10.2 Infectious Diseases
13.10.3 Cancer
13.10.4 Osteoporosis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Peptides Market: Competitive Dashboard
14.2 Global Peptides Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cipla Ltd.
14.3.2 Emcure Pharmaceuticals Pvt. Ltd.
14.3.3 Gland Pharma Limited
14.3.4 Troikaa Pharmaceuticals Ltd.
14.3.5 Biological E Limited
14.3.6 Bharat Biotech
14.3.7 Samarth Life Sciences Pvt. Ltd.
14.3.8 VHB Life Sciences Limited
14.3.9 Celon Laboratories Pvt. Ltd.
14.3.10 United Biotech(P) Limited
